Cargando…

Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk

BACKGROUND: Differences between gastrointestinal and cardiovascular effects of traditional NSAID or cyclooxygenase-2 selective inhibitor (coxib) are affected by drug, dose, duration, outcome definition, and patient gastrointestinal and cardiovascular risk factors. We calculated the absolute risk for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, R Andrew, Derry, Sheena, McQuay, Henry J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001315/ https://www.ncbi.nlm.nih.gov/pubmed/17683540 http://dx.doi.org/10.1186/1471-2474-8-73

Ejemplares similares

Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes
por: Moore, R Andrew, et al.
Publicado: (2008)

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice
por: Moore, R Andrew, et al.
Publicado: (2006)

Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction
por: Moore, R Andrew, et al.
Publicado: (2005)

Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
por: Moore, Robert Andrew, et al.
Publicado: (2014)

Incidence of epidural haematoma and neurological injury in cardiovascular patients with epidural analgesia/anaesthesia: systematic review and meta-analysis
por: Ruppen, Wilhelm, et al.
Publicado: (2006)

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use
por: Straube, Sebastian, et al.
Publicado: (2009)

Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2008)

Infection rates associated with epidural indwelling catheters for seven days or longer: systematic review and meta-analysis
por: Ruppen, Wilhelm, et al.
Publicado: (2007)

Prevalence of anaemia in older persons: systematic review
por: Gaskell, Helen, et al.
Publicado: (2008)

What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
por: Moore, R Andrew, et al.
Publicado: (2008)

Correction: Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2006)

Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
por: Moore, R Andrew, et al.
Publicado: (2005)

Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scores
por: Moore, R Andrew, et al.
Publicado: (2008)

Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
por: Khan, Shanzana, et al.
Publicado: (2019)

Pregabalin in fibromyalgia - responder analysis from individual patient data
por: Straube, Sebastian, et al.
Publicado: (2010)

Vitamin D and Chronic Pain in Immigrant and Ethnic Minority Patients—Investigation of the Relationship and Comparison with Native Western Populations
por: Straube, Sebastian, et al.
Publicado: (2010)

Topical NSAIDs for acute pain: a meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004)

Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis
por: Mason, Lorna, et al.
Publicado: (2004)

Cyclo‐oxygenase selectivity and chemical groups of nonsteroidal anti‐inflammatory drugs and the frequency of reporting hypersensitivity reactions: a case/noncase study in VigiBase
por: Bakhriansyah, Mohammad, et al.
Publicado: (2019)

Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
por: Yeomans, Neville D
Publicado: (2015)

Interference with work in fibromyalgia - effect of treatment with pregabalin and relation to pain response
por: Straube, Sebastian, et al.
Publicado: (2011)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
por: Sostres, Carlos, et al.
Publicado: (2013)

Prevalence of gastrointestinal lesions in dogs chronically treated with nonsteroidal anti‐inflammatory drugs
por: Mabry, Kasey, et al.
Publicado: (2021)

Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids
por: Moore, R Andrew, et al.
Publicado: (2005)

Nonsteroidal Anti-Inflammatory Drugs and the Kidney
por: Hörl, Walter H.
Publicado: (2010)

Nonsteroidal anti‐inflammatory drugs and pharyngitis
por: Mazzone, Stuart B, et al.
Publicado: (2022)

Topical nonsteroidal anti-inflammatory drugs
por: Bhat, Chirag, et al.
Publicado: (2023)

Advent of Novel Phosphatidylcholine-Associated Nonsteroidal Anti-Inflammatory Drugs with Improved Gastrointestinal Safety
por: Lim, Yun Jeong, et al.
Publicado: (2013)

Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study
por: Hensley, Abigail, et al.
Publicado: (2015)

Overt Gastrointestinal Bleeding Secondary to Nonsteroidal Anti-Inflammatory Drug-Induced Jejunal Diverticular Ulcer
por: Sy, Alexander M., et al.
Publicado: (2018)

Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma
por: Jeter, Joanne M., et al.
Publicado: (2011)

Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
por: Schoenberger, Scott D., et al.
Publicado: (2013)

Nonsteroidal Anti-Inflammatory Drugs and Prostatic Diseases
por: Ishiguro, Hitoshi, et al.
Publicado: (2014)

Vigilance in Prescribing Nonsteroidal Anti-inflammatory Drugs
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2017)

Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue
por: Varga, Zoltan, et al.
Publicado: (2017)

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2001)

Adherence to the preventive strategies for nonsteroidal anti-inflammatory drug- or low-dose aspirin-induced gastrointestinal injuries
por: Fujita, Tsuyoshi, et al.
Publicado: (2013)

Clinical Features, Diagnosis, and Treatment Strategies of Gastrointestinal Diaphragm Disease Associated with Nonsteroidal Anti-Inflammatory Drugs
por: Wang, Yan-Zhi, et al.
Publicado: (2016)

Potential Strategies in the Prevention of Nonsteroidal Anti-inflammatory Drugs-Associated Adverse Effects in the Lower Gastrointestinal Tract
por: Guo, Chuan-Guo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dl9ji4uq49jgpjstro9jq0uodk